Form 8-K - Current report:
SEC Accession No. 0001104659-23-037784
Filing Date
2023-03-28
Accepted
2023-03-28 17:15:44
Documents
13
Period of Report
2023-03-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310794d1_8k.htm   iXBRL 8-K 27006
2 EXHIBIT 10.1 tm2310794d1_ex10-1.htm EX-10.1 81355
  Complete submission text file 0001104659-23-037784.txt   304223

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20230324.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20230324_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20230324_pre.xml EX-101.PRE 22595
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2310794d1_8k_htm.xml XML 3595
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 23770617
SIC: 2834 Pharmaceutical Preparations